• Abbott Receives EUA for COVID-19 IgM Antibody Blood Test americanpharmaceuticalreview
    October 16, 2020
    Abbott announced the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company's AdviseDx SARS-CoV-2 IgM (Immunoglobulin M) lab-based serology test for use on the ARCHITECT® and Alinity™ platforms.
PharmaSources Customer Service